NT PHARMA (01011.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug8

NT PHARMA released FY2025 Q1 earnings on August 8 (BJT), actual revenue HKD 6.423 M, actual EPS HKD -0.0162

15:00

Tailem Pharma Reports Increased Mid-Year Loss

08:45

NT PHARMA released FY2025 Q2 earnings on August 8 During-Market (BJT), actual revenue HKD 6.564 M, actual EPS HKD -0.0165

08:00

NT PHARMA released FY2025 Semi-Annual earnings on August 8 During-Market (BJT), actual revenue HKD 12.99 M, actual EPS HKD -0.0327

08:00

Jul31

NT PHARMA to Release FY2025 Semi-Annual Earnings on August 8, 2025 (BJT)

00:59

Jul30

Tailem Pharma Cooperates with State-Owned Enterprise to Launch Smart Healthcare Center

14:07

Schedules & Filings

Schedules

Filings

Aug8

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 6.564 M, Net Income -9.252 M, EPS -0.0165

Mar31

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 3.544 M, Net Income -28.73 M, EPS -0.1088

Aug30

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 16.81 M, Net Income 355.13 K, EPS 0.0013

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More